Everest Organics (Small Cap - High Growth) Share Target 2025, 2026 To 2035
|
Everest Organics Limited |
|||
|
Price: ₹295.00 (-1.99%) | ||
| 52 Week Low: ₹110.00 52 Week High: ₹307.15 |
|||
| Market Capital: 116.2 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Everest Organics Share Price Target For 2025
- 1.1.1: Everest Organics Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Everest Organics Share Price Target For 2026
- 1.2.1: Everest Organics Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Everest Organics Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Everest Organics Financial Performance
- 3.0.1: Is Everest Organics A Good Buy For Long Term?
To predict the Everest Organics's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Everest Organics Share Price Target For 2025
The line chart displays the monthly closing prices of Everest Organics with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Everest Organics shares in 2025, see the table below.
Everest Organics Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 335.0 (+13.55%) | Price Action: Aug 2020 High |
| 2025 Target 2 | 331.6 (+12.4%) | Price Action: Jun 2021 Low |
| 2025 Target 1 | 325.0 (+10.16%) | Price Action: May 2021 Low |
| Current Price | 295.00 | Everest Organics's share price as of 02 Jan 2025 |
| Stop Loss 1 | 281.0 (-4.75%) | Price Action: Dec 2021 High |
| Stop Loss 2 | 277.4 (-5.97%) | Price Action: Feb 2021 High |
| Stop Loss 3 | 273.95 (-7.14%) | Price Action: Jan 2022 High |
Short-Term Technical Outlook
Current Technical Position: Everest Organics is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹227.27 serves as the nearest technical reference point.
Historical Returns: 3-month: +136.19% | 6-month: +85.94% | 1-year: +97.26%
Everest Organics Share Price Target For 2026
The line chart displays the monthly closing prices of Everest Organics with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Everest Organics shares in 2026, see the table below.
Everest Organics Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 445.32 (+50.95%) | Price Action: Chart |
| 2026 Target 2 | 437.02 (+48.14%) | Price Action: Chart |
| 2026 Target 1 | 432.69 (+46.67%) | Fibonacci Extension Level 64.90% |
| Current Price | 295.00 | Everest Organics's share price as of 02 Jan 2025 |
| Stop Loss 1 | 260.0 (-11.87%) | Price Action: Nov 2021 Low |
| Stop Loss 2 | 255.0 (-13.56%) | Price Action: Mar 2021 High |
| Stop Loss 3 | 251.65 (-14.7%) | Price Action: Oct 2020 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Everest Organics is currently trading near its 52-week high of ₹307.15, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +97.26% | 3-year: +12.75% | 5-year: +59.8%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Everest Organics Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹295.00 | ||
| 2025 | ₹306.41 | +3.86% | ₹311.01 |
| 2026 | ₹320.35 | +4.54% | ₹325.16 |
| 2027 | ₹378.86 | +18.26% | ₹384.54 |
| 2028 | ₹467.71 | +23.45% | ₹474.73 |
| 2029 | ₹593.58 | +26.91% | ₹602.48 |
| 2030 | ₹690.79 | +16.37% | ₹701.15 |
| 2031 | ₹889.41 | +28.75% | ₹902.75 |
| 2032 | ₹1,100.56 | +23.74% | ₹1,117.07 |
| 2033 | ₹1,439.11 | +30.76% | ₹1,460.70 |
| 2034 | ₹1,349.85 | -6.2% | ₹1,370.10 |
| 2035 | ₹1,404.86 | +4.07% | ₹1,425.93 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Everest Organics Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 116.2 Crore | Market valuation of Everest Organics's shares. |
| Revenue (TTM) | 197.24 Crore | Total revenue generated by Everest Organics over the past twelve months. |
| Net Income (TTM) | +13.92 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +2.76% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +21.6% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+35.75% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
1.26 | Company's total debt divided by total shareholder equity. |
| Total Debt | 51.4 Crore | Sum of Everest Organics's current & long-term financial obligations. |
Is Everest Organics A Good Buy For Long Term?
Everest Organics, a small-cap stock with a market capitalization of ₹116.2 crore, presents a mixed picture for long-term investors. While its ₹197.24 crore revenue in the last twelve months (TTM) is significant, a net profit of only ₹13.92 lakh reveals extremely low profitability (0.007%). A substantial debt of ₹51.4 crore (Q2 2024-25) further raises concerns. Although past 12-month returns are positive (23.88%), the three-year return of -47.72% indicates significant risk. Considering these factors, Everest Organics is currently a Not a Good Buy for long-term investment. Further investigation into the reasons for low profitability is crucial before considering any investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
